Department of Urology with Kidney Transplant Center, University Hospital, Faculty of Medicine, Bratislava, Slovakia.
Institute of Clinical and Translational Research, Biomedical Research Center, SAS, Bratislava, Slovakia.
BMC Cancer. 2018 May 24;18(1):591. doi: 10.1186/s12885-018-4508-1.
Knowledge about the expression and thus a role of enzymes that produce endogenous HS - cystathionine-β-synthase, cystathionine γ-lyase and mercaptopyruvate sulfurtransferase - in renal tumors is still controversial. In this study we aimed to determine the expression of these enzymes relatively to the expression in unaffected part of kidney from the same patient and to found relation of these changes to apoptosis. To evaluate patient's samples, microarray and immunohistochemistry was used.
To determine the physiological importance, we used RCC4 stable cell line derived from clear cell renal cell carcinoma, where apoptosis induction by a mixture of five chemotherapeutics with/without silencing of HS-producing enzymes was detected. Immunofluorescence was used to determine each enzyme in the cells.
In clear cell renal cell carcinomas, expression of HS-producing enzymes was mostly decreased compared to a part of kidney that was distal from the tumor. To evaluate a potential role of HS-producing enzymes in the apoptosis induction, we used RCC4 stable cell line. We have found that silencing of cystathionine-β-synthase and cystathionine γ-lyase prevented induction of apoptosis. Immunofluorescence staining clearly showed that these enzymes were upregulated during apoptosis in RCC4 cells.
Based on these results we concluded that in clear cell renal cell carcinoma, reduced expression of the HS-producing enzymes, mainly cystathionine γ-lyase, might contribute to a resistance to the induction of apoptosis. Increased production of the endogenous HS, or donation from the external sources might be of a therapeutic importance in these tumors.
关于产生内源性 HS 的酶——胱硫醚-β-合酶、胱硫醚 γ-裂解酶和巯基丙酮酸硫转移酶——在肾肿瘤中的表达及其作用的知识仍存在争议。在这项研究中,我们旨在确定这些酶的表达相对于同一患者未受影响的肾脏部分的表达,并发现这些变化与细胞凋亡的关系。为了评估患者的样本,我们使用了微阵列和免疫组织化学。
为了确定这些酶的生理重要性,我们使用了源自透明细胞肾细胞癌的 RCC4 稳定细胞系,通过用五种化疗药物的混合物诱导凋亡,并在有/无产生 HS 的酶沉默的情况下检测细胞凋亡。免疫荧光用于确定细胞中的每种酶。
在透明细胞肾细胞癌中,与远离肿瘤的肾脏部分相比,产生 HS 的酶的表达大多降低。为了评估 HS 产生酶在诱导细胞凋亡中的潜在作用,我们使用了 RCC4 稳定细胞系。我们发现,沉默胱硫醚-β-合酶和胱硫醚 γ-裂解酶可阻止细胞凋亡的诱导。免疫荧光染色清楚地表明,这些酶在 RCC4 细胞凋亡过程中上调。
基于这些结果,我们得出结论,在透明细胞肾细胞癌中,主要是胱硫醚 γ-裂解酶的 HS 产生酶表达降低,可能导致对细胞凋亡诱导的耐药性。内源性 HS 的增加产生,或从外部来源的捐赠可能对这些肿瘤具有治疗意义。